Bowen Zheng

3PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 27, 2026
Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy (LD-NEPA).

|Feb 13, 2026
Lentiviral Dendritic Cell Vaccine Targeting Claudin-18.2 Elicits Potent Antitumor Immunity Against Gastric Cancer.

Bowen Zheng, Wenqing Zhang, Dan Zhou

|Feb 26, 2025
Deeper Analysis to Identify the True Benefit of ICIs Immunotherapy in First-Line Treatment for Non-HER2-Positive/HER2-Negative Advanced or Metastatic Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC).

Bowen Zheng, Fanzhuoran Lou, Yuting He

Pageof 1

Frequent Collaborators

3 joint publications

Li Xiao

2 joint publications

Weijuan Tan

2 joint publications

Tianhui Hu